A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children

References

• Ng Kee Kwong KC, Mehta PR, Shukla G, Mehta AR. COVID-19, SARS and MERS: a neurological perspective. J Clin Neurosci. 2020;77::13–16. doi:10.1016/j.jocn.2020.04.124.
   PubMed Web of Science ®Google Scholar
• Samaddar A, Gadepalli R, Nag VL, Misra S. The Enigma of low COVID-19 fatality rate in India. Front Genet. 2020 Jul 28;11:854. doi:10.3389/fgene.2020.00854.
   PubMed Web of Science ®Google Scholar
• Franklin R, Young A, Neumann B, Fernandez R, Joannides A, Reyahi A, Modis Y. Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. medRxiv. 2020 Apr 10;20053207. accessed 2020 Apr 10. doi:10.1101/2020.04.10.20053207.
   Google Scholar
• Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, Tie Y, Fullerton KE. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759–65. doi:10.15585/mmwr.mm6924e2.
   PubMed Web of Science ®Google Scholar
• Steinman JB, Lum FM, Ho PP, Kaminski N, Steinman L. Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics. Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24620–26. doi:10.1073/pnas.2012358117.
   PubMed Web of Science ®Google Scholar
• Pawlowski, C., Puranik, A., Bandi, H. et al. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. Sci Rep 11, 4741 (2021). https://doi.org/10.1038/s41598-021-83641-y
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19? Allergy. 2020;75(7):1824–27. doi:10.1111/all.14344.
   PubMed Web of Science ®Google Scholar
• Introduction of Measles Rubella Vaccine (Campaign and Routine Immunization). National Operational Guidelines 2017. Ministry of Health and Family Welfare. Government of India. Accessed 1 Jun 2021. https://main.mohfw.gov.in/sites/default/files/195431585071489665073.pdf
   Google Scholar
• National Family Health Survey (NFHS-5) 2019-2020. Ministry of health and family welfare. Government of India. Accessed 2 June 2021. http://rchiips.org/NFHS/NFHS-5_FCTS/NFHS-5%20State%20Factsheet%20Compendium_Phase-I.pdf
   Google Scholar
• Newtonraj A, Vincent A, Selvaraj K, Manikandan M. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey. Rural Remote Health. 2019 Sep;19(3):5261. doi:10.22605/RRH5261.
   PubMedGoogle Scholar
• Scobie HM, Ray A, Routray S, Bose A, Bahl S, Sosler S, Wannemuehler K, Kumar R, Haldar P, Anand A, et al. Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012. PLoS One. 2015;10(5):e0127105. doi:10.1371/journal.pone.0127105.
   PubMed Web of Science ®Google Scholar
• Priyadharshini JA. Coverage survey of Measles-Rubella mass vaccination campaign in a rural area in Tamil Nadu. J Family Med Prim Care. 2019;8(6):1884–88. doi:10.4103/jfmpc.jfmpc_319_19.
   PubMedGoogle Scholar
• Rajkumari B, Keisam A, Haobam DS, Thounaojam T. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: a cross-sectional study. Indian J Public Health. 2020;64(2):173–77. doi:10.4103/ijph.IJPH_361_19.
   PubMed Web of Science ®Google Scholar
• Patle RA, Wankhade NR. Measlesrubella vaccination campaign: evaluation of coverage in rural area of Central India. Int J Med Sci Public Health. 2019;8:765–68.
   Google Scholar
• Kelvin AA, Halperin S. COVID-19 in children: the link in the transmission chain. Lancet Infect Dis. 2020 Jun;20(6):633–34. doi:10.1016/S1473-3099(20)30236-X.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2019 Jan 7;37(2):219–22. doi:10.1016/j.vaccine.2017.07.066.
   PubMed Web of Science ®Google Scholar
• Elhusseiny KM, Abd-Elhay FA, Kamel MG. Possible therapeutic agents for COVID-19: a comprehensive review. Expert Rev Anti Infect Ther. 2020 Oct;18(10):1005–20. doi:10.1080/14787210.2020.1782742.
   PubMed Web of Science ®Google Scholar
• Gold JE, Baumgartl WH, Okyay RA, Licht WE, Fidel PL, Noverr MC, Tilley LP, Hurley DJ, Rada B, Ashford JW, et al. Analysis of Measles-Mumps-Rubella (MMR) titers of recovered COVID-19 patients. mBio. 2020 Nov;11:6. doi:10.1128/mBio.02628-20.
   Web of Science ®Google Scholar
• Sarma H, Budden A, Luies SK, Lim SS, Shamsuzzaman M, Sultana T, Rajaratnam JK, Craw L, Banwell C, Ali MW, et al. Implementation of the World’s largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation. BMC Public Health. 2019;19(925). doi:10.1186/s12889-019-7176-4.
   Google Scholar
• Pronyk P, Sugihantono A, Sitohang V, Moran T, Kadandale S, Muller S, Whetham C, Kezaala R. Vaccine hesitancy in Indonesia. Lancet Planet Health. 2019 Mar;3(3):e114–e115. doi:10.1016/S2542-5196(18)30287-0.
   PubMedGoogle Scholar
• [accessed 2021 Jan 22]. John Hopkins Corona Virus Resource Centre. https://coronavirus.jhu.edu/data/mortality
   Google Scholar
• Deshpande S, Balaji S. MMR Vaccine and Covid-19: a Myth or a low risk-high reward preventive measure? Indian Pediatr. 2020;57(8):773. doi:10.1007/s13312-020-1941-4.
   PubMed Web of Science ®Google Scholar
• World Health, Organization. Immunological basis for immunization: rubella. World Health Organization; Geneva, Switzerland. Accessed on 1 June 2021. https://apps.who.int/iris/bitstream/handle/10665/43922/9789241596848_eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• Mclean, Huong Q, Hickman, C. J, Seward, Jane F, World Health Organization & Centers for Disease Control and Prevention (‎U.S.)‎. ‎2010‎. The immunological basis for immunization series: module 16: mumps. World Health Organization, Geneva, Switzerland. Accessed on 2 Jun 2021. https://apps.who.int/iris/handle/10665/97885
   Google Scholar
• Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. Dec 1 2020. doi: 10.1136/archdischild-2020-320338
   Web of Science ®Google Scholar
• Han MS, Choi EH, Chang SH, Jin B-L, Lee EJ, Kim BN, Kim MK, Doo K, Seo J-H, Kim Y-J, et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175(1):73–80. doi:10.1001/jamapediatrics.2020.3988.
   PubMed Web of Science ®Google Scholar
• Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, Miller E, Zambon M. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062–67. doi:10.1136/jech.2009.093450.
   PubMed Web of Science ®Google Scholar
• Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623–31. doi:10.1093/ije/dym021.
   PubMed Web of Science ®Google Scholar
• [accessed 2021 Jan 22]. https://clinicaltrials.gov/ct2/show/NCT04475081?cond=MMR+COVID-19&draw=2&rank=
   Google Scholar
• [accessed 2021 Jan 22]. https://clinicaltrials.gov/ct2/show/NCT04357028
   Google Scholar